Pulmonary edema induced by angiotensin I in rats

Japanese Journal of Pharmacology

Volumn 76, Issue 1, 1998, Pages 51-56

  Xu, Zhe Hu ^a   Shimakura, Kazuro ^a   Yamamoto, Takatsugu ^a   Wang, Li Man ^a   Mineshita, Satoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme; Angiotensin I; Losartan; Phentolamine; Pulmonary edema

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN I; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; PHENTOLAMINE; PHENTOLAMINE MESYLATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CARBON DIOXIDE TENSION; BLOOD OXYGEN TENSION; BREATHING RATE; CONTROLLED STUDY; LUNG EDEMA; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT;

EID: 0031913383     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.76.51     Document Type: Article

References (26)

1. Barnett JC, Zink KM and Touchon RC: Sublingual captopril in the treatment of acute heart failure. Curr Ther Res 49, 274-281 (1991)
2. Langes K, Siebels J and Kuck KH: Efficacy and safety of intravenous captopril in congestive heart failure. Curr Ther Res 53, 167-176 (1993)
3. The Consensus Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 316, 1429-1473 (1987)
4. Giles DT: Lisinopril in the treatment of congestive heart failure. J Human Hyperten 3, 83-87 (1989)
5. Kramer BL, Massie MB and Topic N: Control trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation 67, 807-816 (1983)
6. Prewitt RM, McCarthy J and Wood LDH: Treatment of acute low pressure pulmonary edema in dogs. J Clin Invest 67, 409-418 (1981)
7. Hamilton RJ, Carter WA and Gallagher EJ: Rapid improvement of acute pulmonary edema with sublingual captopril. Acad Emerg Med 3, 205-212 (1996)
8. Yang HY, Erdos EG and Leven Y: Characterization of a dipeptide hydrolase (kininase II: angiotensin I-converting enzyme). J Pharmacol Exp Ther 177, 291-300 (1971)
9. Peach MJ: Adrenal medullary stimulation induced by angiotensin I, angiotensin II and analogues. Circ Res Suppl 28, II-107-II-116 (1971)
10. Peach MJ, Bumpus FM and Khatrallah PA: Release of catecholamines by angiotensin I. J Pharmacol Exp Ther 176, 366-376 (1971)
11. Mineshita S and Shigei T: Prevention of adrenaline-induced pulmonary edema by stem bromelain in rabbits and analysis of the hemodynamic changes. Jpn J Pharmacol 20, 373-382 (1970)
12. Shimakura K, Sanaka M, Wang LM, Mineshita S and Miyazaki M: Pulmonary edema induced by angiotensin II in rats. Jpn J Pharmacol 67, 383-389 (1995)
13. Shigei T, Sakuma A, Enomoto T, Oh-ishi S and Hatano R: Pulmonary edema induced by adrenaline and related amines in rats, and its modification by various pretreatments. Jpn J Pharmacol 17, 591-602 (1967)
14. Jackson EK and Garrison JC: Renin and angiotensin. In Goodman and Gilman's The Pharmacological Basis of Therapeutics (Ninth Edition), Edited by Hardman JG, Limbird LE, Molinoff PB, Ruddon RW and Gilman AG, pp 733-758, The McGraw-Hill Companies Inc, New York (1996)
15. Beneli G, DellaBella D and Gandini A: Angiotensin and peripheral sympathetic nerve activity. Br J Pharmacol 22, 211-219 (1964)
16. Day MD and Owera DAA: The interaction between angiotensin and sympathetic vasoconstriction in the isolated artery of the rabbit ear. Br J Pharmacol 34, 499-507 (1968)
17. Farr WC and Grupp G: Sympathetically mediated effects of angiotensin on the dog heart in situ. J Pharmacol Exp Ther 156, 528-537 (1967)
18. Feldberg W and Lewis GP: The action of peptides on the adrenal medulla. Release of adrenaline by bradykinin and angiotensin. J Physiol (Lond) 171, 98-108 (1964)
19. Kinoshita M, Yamaguchi S, Takahashi M, Itoh M, Fukuhara T, Mitsunami K and Kawakita S: Comparative dose-dependent effects of nitroglycerin on epicardial coronary artery, coronary resistance vessel, left ventricular preload and afterload. Jpn Cire J 50, 702-703 (1986)
20. Imhof PR, Otto B, Frankhausen P, Chu LC and Hodler J: Difference in nitroglycerin dose response in the venous and arterial beds. Eur J Clin Pharmacol 18, 455-460 (1980)
21. Staub NC: Pulmonary edema due to increased microvascular permeability to fluid and protein. Circ Res 43, 143-151 (1978)
22. Leeman M, Lejeune P and Naeije R: Inhibition of angiotensin-converting enzyme by perindopril diacid in canine oleic acid pulmonary edema. Crit Care Med 15, 567-573 (1987)
23. Kanazawa H, Kurihara N, Hirata K, Kudoh S, Fujii T, Tanaka S and Takeda T: Angiotensin II stimulates peptide leukotriene production by guinea pig airway via the AT1 receptor pathway. Prostaglandins Leukot Essent Fatty Acids 52, 241-244 (1995)
24. Chauvin B, Richer C and Giudicelli J-F: Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats. Br J Pharmacol 116, 2229-2236 (1995)
25. Cambell DJ, Kladis A and Duncan AM: Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 23, 439-449 (1994)
26. Schlafke ME and Koepchen HP: A systems view of respiratory regulation. In Comprehensive Human Physiology: From Celluar Mechanisms to Integration, Edited by Greger R and Windhorst U, Vol 2, pp 2097-2127, Springer-Verlag, Berlin and Heidelberg (1996)